24.159.1477 CIRCUMSTANCES CONSTITUTING A LOW RISK OF ADVERSE HOMEBIRTH OUTCOMES
(1) A low risk of adverse birth outcomes indicates a clinical scenario for which there is not clear demonstratable benefit for a medical intervention or transfer to a physician's care.
(2) Consultation with a physician does not preclude a low risk of adverse birth outcomes.
(3) Preexisting arrangements for emergency transportation to a nearby hospital if needed do not preclude a low risk of adverse birth outcomes.
(4) The following conditions preclude a low risk of adverse birth outcomes.
(a) Pre-existing conditions (not gynecological):
(i) subarachnoid hemorrhage, aneurysm;
(ii) recent or acute herniated nucleus pulposus;
(iii) active tuberculosis or ongoing treatment;
(iv) human immunodeficiency virus, acquired immunodeficiency syndrome, hepatitis B or hepatitis C;
(v) heart defect with hemodynamic consequences;
(vi) clotting disorders;
(vii) kidney dysfunction;
(viii) hypertension;
(ix) diabetes mellitus;
(x) unmedicated thyroid disorders with present TSH receptor antibodies;
(xi) inflammatory bowel disease, including ulcerative colitis and Crohn's disease;
(xii) systemic and rare disorders, including Addison's disease, Cushing's syndrome, systemic lupus erythematosus, antiphospholipid syndrome, scleroderma, rheumatoid arthritis, polyarteritis nodosa, Raynaud's disease, and Marfan syndrome;
(xiii) illegal drug use; or
(xiv) alcoholism.
(b) Pre-existing gynecological conditions:
(i) pelvic floor reconstruction;
(ii) conization;
(iii) myomectomy or other uterine surgery; or
(iv) uterine distortion, including bicornuate, septate, unicornuate, or didelphic conditions.
(c) Obstetric history:
(i) blood group antagonism, including Rhesus, Kell, Duffy, and Kidd glycoproteins;
(ii) previous pre-term (before 34 weeks) birth. If a normal pregnancy occurred after the premature birth, the current birth may be considered to be low risk;
(iii) cervical insufficiency or cerclage;
(iv) placental abruption;
(v) caesarean section - must transfer current pregnancy at 37 weeks if no reason for transfer prior;
(vi) dysmaturity;
(vii) uncontrolled post-partum hemorrhage;
(viii) manual placental removal;
(ix) placenta accreta; and
(x) total uterine rupture with no functional recovery; or
(xi) history of intrauterine fetal demise.
(d) Occurring or diagnosed during pregnancy:
(i) rubella;
(ii) cytomegalovirus;
(iii) genital herpes (primo infection);
(iv) parvovirus;
(v) tuberculosis;
(vi) human immunodeficiency virus or acquired immunodeficiency syndrome;
(vii) syphilis;
(viii) illegal drug use;
(ix) alcoholism;
(x) maternal anemia;
(xi) extrauterine pregnancy;
(xii) amniotic fluid loss or preterm labor before 37 weeks;
(xiii) uncontrolled diabetes mellitus;
(xiv) gestational diabetes mellitus;
(xv) gestational hypertension with diastolic blood pressure above 100 or systolic blood pressure above 160;
(xvi) preeclampsia, superimposed preeclampsia, hemolysis, or elevated liver enzymes and low platelets (HELLP) syndrome;
(xvii) blood group antagonism;
(xviii) deep vein thrombosis;
(xix) clotting disorders;
(xx) vasa previa;
(xxi) velamentous cord insertion;
(xxii) placenta previa;
(xxiii) placental abruption;
(xxiv) serotonin syndrome;
(xxv) cervical insufficiency prior to 37 weeks of gestation;
(xxvi) multiple pregnancy;
(xxvii) breech or abnormal position at term; or
(xxviii) fetal mortality; or
(xxix) prolonged gestation > 42 weeks.
History: 37-1-131, MCA; IMP, 37-8-202, MCA; NEW, 2023 MAR p. 1561, Eff. 11/4/23.